Statement regarding Mead Johnson

RNS Number : 8437V

Reckitt Benckiser Group PLC

02 February 2017

 

2 February 2017

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION

Reckitt Benckiser Group plc
Statement regarding Mead Johnson

Reckitt Benckiser Group plc ("RB") notes the recent press speculation regarding a possible transaction involving Mead Johnson Nutrition Company ("Mead Johnson").

RB confirms that it is in advanced negotiations to acquire each Mead Johnson share for $90 in cash, valuing Mead Johnson's entire share capital at approximately $16.7 billion.

The parties are presently engaged in a period of due diligence and contract discussion.

RB presently expects to finance the possible transaction through a combination of cash and debt, whilst retaining a strong investment grade credit rating.

There is no certainty that any transaction will ultimately be agreed, nor as to the terms on which any transaction might occur.

A further announcement will be made as appropriate.

For further information, please contact:

RB Richard Joyce SVP, Investor Relations, Communications & External Affairs	[phone]
Brunswick (Financial PR) Gabrielle Silver & David Litterick	[phone]

 

END

 

 

STROKBDQABKKNBK